Customize your JAMA Network experience by selecting one or more topics from the list below.
Ni N, Langer P, Wagner R, Guo S. Topical Timolol for Periocular Hemangioma: Report of Further Study. Arch Ophthalmol. 2011;129(3):373–379. doi:10.1001/archophthalmol.2011.24
Childhood superficial capillary hemangiomas of the eyelid may lead to amblyopia or anisometropia.1,2 Although benign, such tumors can cause irreversible visual loss if not treated promptly. Treatment options for infantile hemangioma include both systemic and intralesional corticosteroids, interferon alfa, laser, embolization, immunomodulators, surgery, and, most recently, propanolol.1,3 Guo and Ni4 first reported successful outcomes for a 4-month-old infant with superficial capillary hemangioma of the eyelid using topical timolol maleate application. We now report a series of 7 children in whom significant reductions of periocular and facial capillary hemangiomas occurred following topical application of timolol maleate, 0.5%, solution.
Create a personal account or sign in to: